Literature DB >> 23159069

Degradation of lidocaine, tramadol, venlafaxine and the metabolites O-desmethyltramadol and O-desmethylvenlafaxine in surface waters.

Paola C Rúa-Gómez1, Wilhelm Püttmann.   

Abstract

The photodegradation and biotic transformation of the pharmaceuticals lidocaine (LDC), tramadol (TRA) and venlafaxine (VEN), and of the metabolites O-desmethyltramadol (ODT) and O-desmethylvenlafaxine (ODV) in the aquatic environmental have been investigated. Photodegradation experiments were carried out using a medium pressure Hg lamp (laboratory experiments) and natural sunlight (field experiments). Degradation of the target compounds followed a first-order kinetic model. Rates of direct photodegradation (light absorption by the compounds itself) at pH 6.9 were very low for all of the target analytes (≤0.0059 h(-1) using a Hg lamp and ≤0.0027 h(-1) using natural sunlight), while rates of indirect photodegradation (degradation of the compounds through photosensitizers) in river water at pH 7.5 were approximately 59 (LDC), 5 (TRA), 8 (VEN), 15 (ODT) and 13 times (ODV) higher than the rates obtained from the experiments in ultrapure water. The accelerated photodegradation of the target compounds in natural water is attributed mainly to the formation of hydroxyl radicals through photochemical reactions. Biotic (microbial) degradation of the target compounds in surface water has been shown to occur at very low rates (≤0.00029 h(-1)). The half-life times determined from the field experiments were 31 (LDC), 73 (TRA), 51 (VEN), 21 (ODT) and 18h (ODV) considering all possible mechanisms of degradation for the target compounds in river water (direct photodegradation, indirect photodegradation and biotic degradation).
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23159069     DOI: 10.1016/j.chemosphere.2012.10.039

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  8 in total

1.  Influence of photolabile pharmaceuticals on the photodegradation and toxicity of fluoxetine and fluvoxamine.

Authors:  Milena Wawryniuk; Agata Drobniewska; Katarzyna Sikorska; Grzegorz Nałęcz-Jawecki
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-21       Impact factor: 4.223

2.  Wastewater analysis: the mean of the monitoring of frequently prescribed pharmaceuticals in Slovakia.

Authors:  Tomáš Mackuľak; Lucia Birošová; Miroslav Gál; Igor Bodík; Roman Grabic; Jozef Ryba; Jaroslav Škubák
Journal:  Environ Monit Assess       Date:  2015-12-09       Impact factor: 2.513

3.  Influence of dihydroxybenzenes on paracetamol and ciprofloxacin degradation and iron(III) reduction in Fenton processes.

Authors:  Beatriz Costa E Silva; João Angelo de Lima Perini; Raquel F Pupo Nogueira
Journal:  Environ Sci Pollut Res Int       Date:  2016-03-14       Impact factor: 4.223

4.  Chromatographic Determination of Aminoacridine Hydrochloride, Lidocaine Hydrochloride and Lidocaine Toxic Impurity in Oral Gel.

Authors:  Lories I Bebawy; Mohamed R Elghobashy; Samah S Abbas; Rafeek F Shokry
Journal:  J Chromatogr Sci       Date:  2015-12-15       Impact factor: 1.618

Review 5.  Studies on photodegradation process of psychotropic drugs: a review.

Authors:  Jakub Trawiński; Robert Skibiński
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-30       Impact factor: 4.223

6.  Photostability studies on (±)-tramadol in a liquid formulation.

Authors:  Manabu Suno; Hidenori Ichihara; Takahiro Ishino; Kento Yamamoto; Yuta Yoshizaki
Journal:  J Pharm Health Care Sci       Date:  2015-02-05

7.  Association between Aquatic Micropollutant Dissipation and River Sediment Bacterial Communities.

Authors:  Claudia Coll; Raven Bier; Zhe Li; Silke Langenheder; Elena Gorokhova; Anna Sobek
Journal:  Environ Sci Technol       Date:  2020-10-26       Impact factor: 9.028

8.  Development and Validation of an RP-HPLC-PDA Method for Determination of Paracetamol, Caffeine and Tramadol Hydrochloride in Pharmaceutical Formulations.

Authors:  Fernando J Pereira; Aida Rodríguez-Cordero; Roberto López; Luis C Robles; A Javier Aller
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.